Whitepaper - Pharmaceutical Executive



Renewed Scrutiny: Drug Discount Program Faces Uncertain Future

October 1, 2013

Even as it is set to dramatically expand, a popular federal drug discount program known as 340B draws fresh scrutiny

Applying Data to Improve Patient-Centric and Personalized Medicine

August 30, 2013

At the 10th Annual SAS Health Care & Life Sciences Executive Conference, SAS brought together great minds from across the industry – provider, pharma, payer and policy sectors – to discuss how data and analytics are advancing the triple aim of better care and improved health at a lower cost.

Rx Risk-Management: Making the Case for FMEA

August 30, 2013

Learn why FMEA, or Failure Mode and Effects Analysis, should be the standard methodology used in pharmaceutical risk-management and how it can reduce the patient's risk at each step of the medication use process.

5-Minute Guide to Analytics in Pharmaceutical Emerging Markets

July 18, 2013

Over the next five years, two-thirds of pharmaceutical sales growth will come from emerging markets. While this presents enormous potential, how can organizations compete to capture new opportunities? It comes down to the data. Emerging markets present fertile ground for growth, but each must be understood to break into and capture potential.

Life-Cycle Marketing

July 10, 2013

Providing patient access solutions to pharmaceutical partners is no longer a one size fits all proposition. Life-cycle marketing addresses access strategies from a brands? pre-launch through patent expiry phases.

Analytics in Copay Assistance Programs

July 10, 2013

An investment in brand program analytics represents an opportunity for a brand to increase marketshare, manage budget and maximize ROI. Learn more about investing in metrics to maximize your patient access solutions.

Factors and Solutions Driving Commercial Co-pay Assistance Programs

June 5, 2013

The importance of determining the role of commercial co-pay assistance in access strategies and putting programs in place that benefit patients while helping drive value for all stakeholders, including payers.

Learning to Share - Sharing to Learn: Honoring Patients Through Collaboration and Transparency

June 1, 2013

As more companies move to share their clinical trial information, the likelihood for identifying new medical breakthroughs is greatly increased and the time to market for safe, effective treatments is decreased. This paper outlines the potential value of data sharing initiatives and the hurdles to creating a successful data sharing environment.

Connected CRM in Life Sciences

May 14, 2013

This paper focuses on how customer centricity can unlock significant financial gains for pharmaceutical companies. It briefly reviews the historical promotion model, the factors in the industry that are driving the change, and then goes into depth on what it means to be customer centric and how to implement a customer-centric model.


Click here